PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
δ-valerolactone 208-807-1 542-28-9 - - 1 - - - - - - Details
ε-caprolactam 203-313-2 105-60-2 - - 1 - - - - - - Details
ε-Caprolactone, oligomeric reaction products with propylidynetrimethanol 500-099-5 37625-56-2 - - 1 - - - - - - Details
λ²-iron(2+) lithium(1+) phosphate 476-700-9 1199808-36-0 - - 1 - - - - - - Details
≥ 76.9% 3-[(1RS,3RS)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin and ≤ 23.1% 3-[(1RS,3SR)-3-(4′-bromobiphenyl-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxycoumarin - - - - - - - 1 - - - Details
((3-(sec-butyl)-4-(decyloxy)phenyl)methanetriyl)tribenzene 801-941-7 1404190-37-9 - - 2 - 1 - - - - Details
((4-phenylbutyl)hydroxyphosphoryl)acetic acid
SQ 26999
412-170-7 83623-61-4 - - - - 1 - - - - Details
(+)-bornan-2-one 207-355-2 464-49-3 - - - - 1 - - - - Details
(+)-menthol 239-387-8 15356-60-2 - - - - 1 - - - - Details
(+)-N-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutyramide 211-569-1 667-83-4 - - - - 1 - - - - Details
(+)-neomenthol 218-691-4 2216-52-6 - - - - 1 - - - - Details
(+-)-(3aRS,5aSR,9aSR,9bSR)-3a,6,6,9a-Tetramethyldodecahydronaphtho[2,1-b]furan 948-069-4 - - - 1 - 1 - - - - Details
(-)-Methyl (S)-2-chloropropionate 625-379-5 73246-45-4 - - - - 1 - - - - Details
(-)-pin-2(10)-ene 242-060-2 18172-67-3 1 - 1 - 1 - - - - Details
(1,1,3,3-tetramethylbutyl)phenol 248-310-7 27193-28-8 - - - - 1 - - - - Details
(1-methylethyl)-1,1'-biphenyl 247-156-8 25640-78-2 1 - 2 - 1 - - - - Details
(1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyl) bismethacrylate 246-263-7 24448-20-2 - - - - 1 - - - - Details
(1-methylethylidene)bis(4,1-phenyleneoxy-3,1-propanediyl) bismethacrylate 248-607-1 27689-12-9 1 - - - 1 - - - - Details
(1-methylethylidene)bis[4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)] bismethacrylate 216-367-7 1565-94-2 - - - - 1 - - - - Details
(1-methylethylidene)bis[4,1-phenyleneoxy(2-hydroxy-3,1-propanediyl)] diacrylate 225-144-3 4687-94-9 - - - - 1 - - - - Details
(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate 425-220-8 5945-33-5 - - 11 - 1 1 - - - Details
(1-phenylethyl)xylene 255-068-6 40766-31-2 - - - - 1 - - - - Details
(1E,9E)-cyclohexadeca-1,9-diene 429-620-3 110028-14-3 - - - - 1 - - - - Details
(1R)-1-isopropyl-4-methyl-cyclohex-3-en-1-ol 943-985-0 20126-76-5 - - - - 1 - - - - Details
(1R)-1-Naphthylethylamine Hydrochloride 617-358-4 82572-04-1 - - - - 1 - - - - Details
(1R)cyclohex-3-enecarboxylic acid (1S)-1-phenylethylamine 814-700-6 67976-81-2 - - - - 1 - - - - Details
(1R,2R)-cyclohexane-1,2-diamine (2R,3R)-2,3-dihydroxybutanedioic acid 609-759-8 39961-95-0 - - - - 1 - - - - Details
(1R,2S)-2,6-dimethyl-2,3-dihydro-1H-inden-1-amine 700-140-9 - - - - - 1 - - - - Details
(1R,2S)-cyclohexane-1,2-diamine; sulfuric acid 613-794-4 65433-80-9 - - - - 1 - - - - Details
(1R,3S,4S,5S)-4,6,6-trimethylspiro[bicyclo[3.1.1]heptane-3,4'-cyclohex-2-ene]-1'-one 430-460-1 133636-82-5 - - - - 1 - - - - Details
(1R,6S)- 4,7,7-trimethylbicyclo[4.1.0]hept-3-en-2-one 606-984-3 22327-32-8 - - - - 1 - - - - Details
(1S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one 225-160-0 4695-62-9 - - - - 1 - - - - Details
(1S)-1-NAPHTHYLETHYLAMINE 436-100-1 - - - - - 1 - - - - Details
(1S)-1-phenylpropan-1-amine 455-040-5 3789-59-1 - - - - 1 - - - - Details
(1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol 805-440-4 22972-51-6 - - - - 1 - - - - Details
(1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride 220-384-5 2746-19-2 - - - - 1 - - - - Details
(1α,2β,5α)-2,6,6-trimethylbicyclo[3.1.1]heptane 229-978-9 6876-13-7 - - - - 1 - - - - Details
(2,3-dimethylbut-2-yl)-trimethoxysilane 439-360-2 142877-45-0 - - - - 1 - - - - Details
(2,4,6-trioxotriazine-1,3,5(2H,4H,6H)-triyl)tris(hexamethylene) isocyanate 223-242-0 3779-63-3 - - 1 - 1 - - - - Details
(2,4,6-trioxotriazine-1,3,5(2H,4H,6H)-triyl)tris(methyl-m-phenylene) isocyanate 247-840-6 26603-40-7 - - - - 1 - - - - Details
(2-chloro-1,1-dimethylethyl)benzene 208-197-7 515-40-2 - - - - 1 - - - - Details
(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride
QUANTACURE QTX
402-200-7 103430-24-6 - - - - 1 - - - - Details
(2-hydroxy-3-sulphopropyl)dimethyl[3-[(1-oxododecyl)amino]propyl]ammonium hydroxide 242-893-1 19223-55-3 - - 1 - 1 - - - - Details
(2-hydroxypropyl)ammonium citrate 250-342-1 30798-32-4 - - - - 1 - - - - Details
(2-hydroxypropyl)trimethylammonium 2-ethylhexanoate 263-502-0 62314-22-1 - - - - 1 - - - - Details
(2-methoxyethyl)benzene 222-619-7 3558-60-9 - - 2 - 1 - - - - Details
(2-methylpropyl)lithium isobutyllithium 440-620-2 920-36-5 - - - - 1 - - - - Details
(2-{[Carboxy-(2-hydroxy-5-sulfo-phenyl)-methyl]-amino}-ethylamino)-(2-hydroxy-5-sulfo-phenyl)-acetic acid 611-514-5 57368-07-7 - - - - 1 - - - - Details
(2R,3S,4R)-2-(Hydroxymethyl)-5-methoxytetrahydrofuran-3,4-diol 857-672-0 13039-63-9 - - - - 1 - - - - Details
(2S)-2-[2-[[(1S)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid 439-840-1 161233-89-2 - - 2 - 1 - - - - Details

Export search results to: